Genome-wide CRISPR screens illuminate lymphoma pathogenesis and therapeutic resistance

被引:0
|
作者
Staudt, Louis M. [1 ]
机构
[1] NCI, Bethesda, MD 20892 USA
关键词
D O I
10.1158/1538-8514.SYNTHLETH-IA09
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IA09
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment
    Xue, Vivian Weiwen
    Wong, Sze Chuen Cesar
    Cho, William Chi Shing
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (11) : 1147 - 1158
  • [2] Genome-wide CRISPR screens and their applications in infectious disease
    Srivastava, Kaveri
    Pandit, Bhaswati
    FRONTIERS IN GENOME EDITING, 2023, 5
  • [3] Using Genome-wide CRISPR Screens to Determine Mechanisms of Drug Resistance in Pancreatic Adenocarcinoma
    Alyateem, George
    Wade, Heidi
    Chan, Dalen
    Robey, Robert
    Batista, Pedro
    Gottesman, Michael
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 391 - 392
  • [4] Finding determinants of PARP inhibitor resistance using genome-wide and focused CRISPR screens
    Pettitt, S.
    Krastev, D.
    Song, F.
    Frankum, J.
    Brough, R.
    Brandsma, I.
    Lee, J. M.
    Swisher, E.
    Ashworth, A.
    Lord, C.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E29 - E29
  • [5] Genome-wide CRISPR screens identify ferroptosis as a novel therapeutic vulnerability in acute lymphoblastic leukemia
    Lalonde, Marie-Eve
    Sasseville, Marc
    Gelinas, Anne-Marie
    Milanese, Jean-Sebastien
    Beland, Kathie
    Drouin, Simon
    Haddad, Elie
    Marcotte, Richard
    HAEMATOLOGICA, 2023, 108 (02) : 382 - 393
  • [6] Deciphering essential cistromes using genome-wide CRISPR screens
    Fei, Teng
    Li, Wei
    Peng, Jingyu
    Xiao, Tengfei
    Chen, Chen-Hao
    Wu, Alexander
    Huang, Jialiang
    Zang, Chongzhi
    Liu, X. Shirley
    Brown, Myles
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (50) : 25186 - 25195
  • [7] Genome-wide CRISPR screens identify therapeutic targets for HNF1A-deficient diabetes
    Cuenca-Ardura, M.
    De Vas, M.
    Balboa, D.
    Ferrer, J.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S162 - S162
  • [8] Genome-wide CRISPR screens reveal genetic mediators of cereblon modulator toxicity in primary effusion lymphoma
    Patil, Ajinkya
    Manzano, Mark
    Gottwein, Eva
    BLOOD ADVANCES, 2019, 3 (14) : 2105 - 2117
  • [9] Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors
    Schleicher, Emily M.
    Dhoonmoon, Ashna
    Jackson, Lindsey M.
    Clements, Kristen E.
    Stump, Coryn L.
    Nicolae, Claudia M.
    Moldovan, George-Lucian
    PLOS GENETICS, 2020, 16 (11):
  • [10] Applying genome-wide CRISPR-Cas9 screens for therapeutic discovery in facioscapulohumeral muscular dystrophy
    Lek, Angela
    Zhang, Yuanfan
    Woodman, Keryn G.
    Huang, Shushu
    DeSimone, Alec M.
    Cohen, Justin
    Ho, Vincent
    Conner, James
    Mead, Lillian
    Kodani, Andrew
    Pakula, Anna
    Sanjana, Neville
    King, Oliver D.
    Jones, Peter L.
    Wagner, Kathryn R.
    Lek, Monkol
    Kunkel, Louis M.
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (536)